Outset Medical to Present at the BofA Securities 2022 Healthcare Conference
26 Avril 2022 - 10:05PM
Business Wire
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical
technology company pioneering a first-of-its-kind technology to
reduce the cost and complexity of dialysis, today announced that
members of management will present at the BofA Securities 2022
Healthcare Conference on Tuesday, May 10, 2022 at 12:00pm PT /
3:00pm ET.
A live and archived webcast of the fireside chat will be
available on the “Investors” section of the Outset website at
https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a
first-of-its-kind technology to reduce the cost and complexity of
dialysis. The Tablo Hemodialysis System, FDA cleared for use from
the hospital to the home, represents a significant technological
advancement that transforms the dialysis experience for patients
and operationally simplifies it for providers. Tablo serves as a
single enterprise solution that can be utilized across the
continuum of care, allowing dialysis to be delivered anytime,
anywhere and by anyone. The integration of water purification and
on-demand dialysate production enables Tablo to serve as a dialysis
clinic on wheels, with 2-way wireless data transmission and a
proprietary data analytics platform powering a new holistic
approach to dialysis care. Tablo is a registered trademark of
Outset Medical, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220426005824/en/
Jim Mazzola Vice President, Investor Relations
jmazzola@outsetmedical.com
Brian Johnston Gilmartin Group (332) 895-3222
investors@outsetmedical.com
Grupo Aeroportuario del ... (NASDAQ:OMAB)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Grupo Aeroportuario del ... (NASDAQ:OMAB)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024